Bank of America
OLMA icon

Bank of America’s Olema Pharmaceuticals OLMA Stock Holding History

Bank of America’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.58M Buy
508,706
+269,792
+113% +$6.01M ﹤0.01% 3158
2025
Q4 		$5.97M Sell
238,914
-563,390
-70% -$10M ﹤0.01% 3241
2025
Q3 		$7.85M Buy
802,304
+2,802
+0.4% +$16.8K ﹤0.01% 3553
2025
Q2 		$3.41M Sell
799,502
-109,046
-12% -$486K ﹤0.01% 4280
2025
Q1 		$3.42M Buy
908,548
+43,209
+5% +$217K ﹤0.01% 4193
2024
Q4 		$5.04M Buy
865,339
+454,400
+111% +$4.54M ﹤0.01% 3579
2024
Q3 		$4.91M Buy
410,939
+277,544
+208% +$3.55M ﹤0.01% 3746
2024
Q2 		$1.44M Sell
133,395
-193,424
-59% -$2.1M ﹤0.01% 4668
2024
Q1 		$3.7M Buy
326,819
+286,709
+715% +$3.7M ﹤0.01% 3903
2023
Q4 		$563K Buy
40,110
+2,227
+6% +$29.9K ﹤0.01% 5411
2023
Q3 		$468K Buy
37,883
+15,604
+70% +$159K ﹤0.01% 5359
2023
Q2 		$201K Sell
22,279
-7,114
-24% -$43K ﹤0.01% 5825
2023
Q1 		$102K Buy
29,393
+1,042
+4% +$4.25K ﹤0.01% 6248
2022
Q4 		$69.5K Buy
28,351
+14,467
+104% +$42.2K ﹤0.01% 6374
2022
Q3 		$38K Sell
13,884
-39,896
-74% -$169K ﹤0.01% 6793
2022
Q2 		$219K Sell
53,780
-102,202
-66% -$324K ﹤0.01% 6026
2022
Q1 		$664K Buy
155,982
+40,816
+35% +$225K ﹤0.01% 5612
2021
Q4 		$1.08M Buy
115,166
+89,864
+355% +$1.86M ﹤0.01% 5164
2021
Q3 		$698K Buy
25,302
+21,545
+573% +$582K ﹤0.01% 5379
2021
Q2 		$105K Sell
3,757
-23,659
-86% -$673K ﹤0.01% 6501
2021
Q1 		$910K Buy
27,416
+27,321
+28,759% +$1.17M ﹤0.01% 4915
2020
Q4 		$5K Buy
+95
New +$4.45K ﹤0.01% 6825

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bank of America's OLMA Position: Q1 2026 in Review

Bank of America increased its Olema Pharmaceuticals (OLMA) stake by 113% in Q1 2026, buying an estimated $6.01M and bringing the position to 508,706 shares worth $7.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

Bank of America first reported a position in OLMA in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.85M in Q3 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Bank of America held 508,706 shares of Olema Pharmaceuticals worth $7.58M as of Q1 2026.
  • Bank of America bought 269,792 Olema Pharmaceuticals shares in Q1 2026, an estimated $6.01M.
  • Olema Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3158 holding.
  • Bank of America first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Bank of America's Olema Pharmaceuticals position peaked at $7.85M in Q3 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.